Novo Nordisk A/S won approval to sell a pill version of its obesity shot Wegovy in the US. Novo will start selling the pill, the first of the blockbuster GLP-1 class, in the US in early January. It is approved to help people lose weight or maintain previous weight loss over the long term. Bloomberg’s Amber Tong reports.
——–
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don’t miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9
Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.
Connect with Bloomberg Television on:
X: https://twitter.com/BloombergTV
Facebook: https://www.facebook.com/BloombergTelevision
Instagram: https://www.instagram.com/bloombergtv/
Connect with Bloomberg Business on:
X: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/
TikTok: https://www.tiktok.com/@bloombergbusiness?lang=en
Reddit: https://www.reddit.com/r/bloomberg/
LinkedIn: https://www.linkedin.com/company/bloomberg-news/
More from Bloomberg:
Bloomberg Radio: https://twitter.com/BloombergRadio
Bloomberg Surveillance: https://twitter.com/bsurveillance
Bloomberg Politics: https://twitter.com/bpolitics
Bloomberg Originals: https://twitter.com/bbgoriginals
Watch more on YouTube:
Bloomberg Technology: https://www.youtube.com/@BloombergTechnology
Bloomberg Originals: https://www.youtube.com/@business
Bloomberg Quicktake: https://www.youtube.com/@BloombergQuicktake
Bloomberg Espanol: https://www.youtube.com/@bloomberg_espanol
Bloomberg Podcasts: https://www.youtube.com/@BloombergPodcasts
source
![[gpt3]rewrite this title and make it good for SEOIsraels CPI rose 0.4% in March[/gpt3]](https://i1.wp.com/res.cloudinary.com/globes/image/upload/t_800X392/v1708271621/COT_Pic/800_dhyhp5.jpg?w=120&resize=120,86&ssl=1 "[gpt3]rewrite this title and make it good for SEOIsraels CPI rose 0.4% in March[/gpt3]")
